Nathan G. Brower, Executive Vice President and General Counsel of Nature's Sunshine Products Inc., has reported several stock transactions in a recent SEC filing. These transactions, which occurred on November 4, 2026, reflect Brower's ongoing engagement with the company and its performance-based compensation structure. This update is significant as it underscores how executive compensation is increasingly tied to company performance metrics.

Nature's Sunshine Products Inc. specializes in pharmaceutical preparations and is incorporated in Utah. The company is publicly traded under the ticker symbol NATR. The recent filing is part of a series of disclosures made by Brower, with the most recent prior filing on May 22, 2026. The company has been actively managing its growth strategy in a competitive landscape.

According to the filing, Brower engaged in multiple transactions involving common shares of Nature's Sunshine Products. He acquired a total of 2,308 shares, with 717 shares acquired as part of a performance-based vesting event related to an adjusted EBITDA milestone of $46.2 million. Additionally, 291 shares were withheld to cover taxes upon the vesting of restricted stock units granted on the same date. Brower’s total ownership following these transactions stands at 44,811 shares.

The transactions may impact stakeholders, including shareholders and potential investors, as they reflect the alignment of executive incentives with company performance. The filing indicates that Brower's compensation is directly linked to achieving specific financial milestones, which could enhance investor confidence in the company's leadership.

Looking ahead, further filings may provide additional insights into executive compensation and performance metrics at Nature's Sunshine Products. The filing does not specify what happens next regarding Brower's compensation structure or any upcoming corporate actions.